Mama-Match
Belle Health review
Belle advertises supply-dependent prices and clinical support; a February 2026 FDA warning letter concerned misleading presentation of compounded products.
- Ask about HSA/FSA
- Independently scored
- Confirm total cost
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
Other providers to compare with Belle Health
Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.
- Meet CoreAge Rx
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
- Meet Sprout Health
$149 or $199 every four weeks; separate annual prepayment and a September 2025 FDA warning letter.
- Meet Sesame
Brand only: Wegovy pill from about $149/mo, Zepbound about $349–$499/mo, with a real video visit — pricier and with more moving parts than a flat compounded plan, but transparent.
Belle Health at a glance
- Semaglutide
- Total varies by supply; billing schedule unconfirmed
- Tirzepatide
- Total varies by supply; billing schedule unconfirmed
- Coverage
- Claims all fifty states
- Brand-name
- Compounded only
How we scored Belle Health
The Mama-Match Score of 67/100 for Belle Health combines six editorial assessments using the same weighted six-factor framework we apply to every provider. It is not a clinical quality rating. A recent source check does not mean every factor was rescored; read the published terms and the methodology alongside the number. Referral payments do not change the score.
Considers the intake steps, payment timing and information available before enrollment.
Considers the full treatment cost, introductory offers and billing commitments.
Considers the described clinical team, appointment access and ways to contact a prescriber.
Considers published state coverage and treatment-specific eligibility limits.
Considers follow-up appointments, refill reviews and access to ongoing clinical support.
Considers cancellation deadlines, refund limits and prepaid commitments.
How we verified this review
- Last reviewed
- October 2026
- Confidence
- Medium
- Primary sources
Company website and regulatory records
Supply-dependent prices and a February 2026 FDA warning letter; the current disclaimer does not establish regulatory resolution.
Pricing
Prices re-verified
Compounded semaglutide
$199
Plan
1-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded semaglutide
$135
Plan
2-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded semaglutide
$119
Plan
6-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded semaglutide
$109
Plan
12-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded tirzepatide
$249
Plan
1-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded tirzepatide
$219
Plan
2-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded tirzepatide
$199
Plan
6-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Compounded tirzepatide
$179
Plan
12-month supply
Advertised monthly equivalent; billing interval and total charge unconfirmed.
Ask your account administrator whether the exact charges qualify for HSA/FSA reimbursement and what itemized receipts you need. Prices reflect what Belle Health disclosed publicly at our last review and change often; confirm the current number on Belle Health's site.
What we like
- Publishes a supply-length price menu
- Describes included nursing and nutrition support
- Identifies pharmacies and clarifies Belle does not compound the products
The caveats
- The February 2026 FDA warning letter identified misleading compounded-product presentation; current disposition is not established
- Lowest figures depend on longer supplies and do not confirm billing schedules
- Shipped prescription medication is nonrefundable under its terms
The FDA letter belongs in the decision
Belle received an FDA warning letter dated February 20, 2026 concerning misleading presentation of compounded semaglutide and tirzepatide. The agency said pictured Belle labels suggested that Belle compounded the drugs when it did not. Its current website says product imagery is illustrative and Belle is not the manufacturer or compounder. That observable disclaimer is useful, but it does not establish the regulator’s current disposition. A reader should weigh this documented marketing finding alongside the care and cost offer, rather than treating a lower price as reassurance.
Short supply and long supply have different prices
The current treatment cards quote semaglutide at $199 per month for one month of supply, $135 for two, $119 for six and $109 for twelve. Tirzepatide is $249, $219, $199 and $179 respectively. The lowest figures therefore refer to the longest supply choices, not a first month available to every patient. These are advertised monthly equivalents; the cards do not settle the actual charge schedule. Multiplying a monthly equivalent by the stated supply length illustrates a budget, but is not proof of the amount or timing charged.
A long supply is a different commitment
A lower monthly equivalent may suit someone with an established treatment plan better than someone still assessing tolerability. The offer needs to clarify how much medicine is dispensed, whether later shipments depend on review and what happens if the prescription changes. Long supply does not itself establish monthly billing or a flexible subscription. Belle describes clinician oversight, nurse and nutrition support and delivery as included. Those features add context, but the precise appointment access and any remaining charges should match the accepted plan.
Pharmacy identification matters more than branded imagery
The treatment pages identify dispensing relationships, including Boudreaux, VialsRx and ReviveRX for semaglutide, with a broader roster for tirzepatide. Pharmacy names can help a patient understand who fills the prescription, rather than assuming the Belle label identifies the compounder. These are seller disclosures, not an independent pharmacy inspection or license check. Belle claims service in all fifty states, subject to an appropriate prescription. Compounded preparations are not FDA approved; brand-style packaging does not change that distinction or demonstrate equivalence to an approved product.
Shipped prescriptions have a refund boundary
The terms permit subscriptions to renew unless canceled before renewal and direct cancellation requests to support with an order number. Shipped prescription or compounded products are not returnable or refundable under that policy. An incorrect or defective product should be reported within seven days of delivery. That reporting window is different from a general satisfaction refund. The exact advance cutoff and treatment of an unused longer-supply balance are not established by the pricing cards. Those details matter before agreeing to a long commitment.
A care offer does not establish maternal suitability
Nutrition and nursing support can be useful parts of a program, but do not establish pregnancy or breastfeeding suitability for the prescribed preparation. A patient planning pregnancy, currently nursing or taking other medicines needs formulation-specific advice from the prescriber. Belle’s most concrete comparisons are its supply-dependent price menu, stated support and shipping refund boundary. The regulatory letter remains a separate concern, and neither a discount nor a revised website disclaimer resolves it.
The bottom line
Best for: Someone comparing supply, support and refund terms while considering the documented FDA finding.
Keep comparing Belle Health
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
Belle Health, answered
- Is the lowest price for just one month?
- No. Semaglutide $109 and tirzepatide $179 are monthly equivalents for twelve months of supply; one month is displayed at $199 and $249. Billing schedules need confirmation.
- Has the FDA letter been resolved?
- The February 2026 letter documents misleading presentation. The current disclaimer that Belle does not compound medicines does not establish regulatory resolution.
- Can shipped medication be returned?
- Terms do not permit returns or refunds of shipped prescriptions. Incorrect or defective products should be reported within seven days of delivery; cancellation before renewal is requested through support.
Prices, states and verification reflect what Belle Health disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.